Furthermore, when utilizing another mode of HIF-1α/SEPT9_i1 complex disruption such as reducing the dissociation of SEPT9_i1 filaments from the complex by FCF leads to the inhibition of the HIF-1 pathway and suppression of tumorigenic properties of prostate cancer cells [30, 37]. The gene discussed is SETD2; the disease is prostate carcinoma.